This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
February 14, 2019
Targovax ASA: Fourth quarter and full year 2018 results
February 14, 2019
MIPS – Year end report 2018
February 13, 2019
Vicore Pharma postpones publication of year-end report
February 13, 2019
Correction of error Q3 (18) report
February 12, 2019
Intravitreal administration of GS010 in patients with LHON was safe and well tolerated
February 11, 2019
First patient treated in dose expansion cohort of Targovax’s ONCOS-102 trial in melanoma
February 08, 2019
BONESUPPORT – Publication of pre-clinical study highlighting unique bone remodeling qualities of CERAMENT® in large bone defects
February 04, 2019
GenSight Biologics reports topline results at Week 48 of the RESCUE Phase III clinical trial of GS010 in subjects within six months of visual loss onset due to Leber Hereditary Optic Neuropathy (LHON)
February 01, 2019
BONESUPPORTTM and Lund University to present at Orthopaedic Research Society (ORS) 2019 Annual Meeting
January 30, 2019
Q4 incl. Full Year Report 2018